Genetically engineered long-acting Esculentin-2CHa(1−30) fusion protein with potential applicability for the treatment of NAFLD-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genetically engineered long-acting Esculentin-2CHa(1−30) fusion protein with potential applicability for the treatment of NAFLD

Published:2024-08 Issue: Volume:372 Page:699-712
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Lee Jaewoong,Amatya Reeju,Kim Kyung Eun,Park Young-Hoon,Hong Eunmi,Djayanti Krismala,Min Kyoung Ah,Roh Gu Seob,Shin Meong Cheol

Funder

Ministry of Trade, Industry and Energy

Korea Evaluation Institute of Industrial Technology

National Research Foundation of Korea

Ministry of Science, ICT and Future Planning

Korea Ministry of Science and ICT

Publisher

Elsevier BV

Reference36 articles.

1. Mechanisms of NAFLD development and therapeutic strategies;Friedman;Nat. Med.,2018

2. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis;Riazi;Lancet Gastroenterol. Hepatol.,2022

3. Nonalcoholic fatty liver disease and recent guideline updates;Ando;Clin. Liver Disease,2021

4. Advancing the global public health agenda for NAFLD: a consensus statement;Lazarus;Nat. Rev. Gastroenterol. Hepatol.,2022

5. The complex link between NAFLD and type 2 diabetes mellitus—mechanisms and treatments;Targher;Nat. Rev. Gastroenterol. Hepatol.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP